Your browser doesn't support javascript.
loading
Clinical Benefit of Bevacizumab and Irinotecan (BEV+IRI) in Patients With Relapsed/Refractory Glioblastoma (r/rGBM) and its Potential Predictors.
Park, Ji Hyun; Lee, Hyun Seok; Choi, Jin Woo; Lim, So Dug; Koh, Hyeon Kang; Cho, Kyung Rae; Cho, Joon; Koh, Young-Cho; Yoon, So Young.
Afiliação
  • Park JH; Department of Hemato-Oncology, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea.
  • Lee HS; Department of Neurosurgery, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea.
  • Choi JW; Department of Radiology, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea.
  • Lim SD; Department of Pathology, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea.
  • Koh HK; Department of Radiation Oncology, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea.
  • Cho KR; Department of Neurosurgery, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea.
  • Cho J; Department of Neurosurgery, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea.
  • Koh YC; Department of Neurosurgery, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea.
  • Yoon SY; Department of Hemato-Oncology, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea greentea@kuh.ac.kr.
Anticancer Res ; 42(12): 6091-6098, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36456153
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2022 Tipo de documento: Article